Beta-Sitosterol
Beta-Sitosterol
A plant sterol studied for supporting prostate health, urinary function, and healthy cholesterol levels.
Beta-Sitosterol is one of the most common plant sterols found in foods like nuts, seeds, and vegetables. It's particularly well-studied for prostate health, with multiple clinical trials showing benefits for BPH symptoms. It also helps lower cholesterol absorption in the gut, making it useful for cardiovascular health.
Mechanisms of Action
5-Alpha Reductase Inhibition
May reduce DHT in prostate tissue
Cholesterol Competition
Blocks cholesterol absorption in the gut
Recommended Dose
60-130mg daily for prostate; 2-3g for cholesterol
Loading: Not required
Optimal Timing
- With meals (especially for cholesterol benefits)
- Divided doses
Take with food
Best Form
Standardized phytosterol complex
Alternatives: Beta-sitosterol isolate, Plant sterol-enriched foods
Often sold as mixed phytosterols. Check label for actual beta-sitosterol content.
Duration
Minimum: 4 weeks
Optimal: 12 weeks
Cycling: Not required
Note: For cholesterol benefits, take with meals to compete with dietary cholesterol absorption.
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Improved Urinary Function
Better urinary flow and reduced symptoms
LDL Reduction
Modest lowering of LDL cholesterol
Well-supported use; get proper diagnosis first
Who Should NOT Take This
- Sitosterolemia (rare genetic condition)
Drug Interactions
Similar mechanisms; may be redundant
Possible Side Effects
Tip: Take with food
Warnings
- Get proper prostate evaluation before self-treating
- May reduce absorption of fat-soluble vitamins at high doses
Top studies from 40+ peer-reviewed papers
Tian M et al. • Phytomedicine : international journal of phytotherapy and phytopharmacology (2026)
“XSLJZD may improve RE symptoms as an adjunctive therapy, but the evidence is low in certainty.”
Key Findings:
- Eight RCTs (n = 646) showed that XSLJZD significantly improved clinical outcomes compared with controls, demonstrating superior overall efficacy and reduced recurrence.
- XSLJZD may improve RE symptoms as an adjunctive therapy, but the evidence is low in certainty.
- The proposed anti-inflammatory and apoptotic mechanisms are computationally derived.
- High-quality trials and experimental validation are needed to confirm efficacy and mechanisms of action.
Zhang L et al. • Medicine (2025)
“QJWJ is effective in the treatment of asthma, and the therapeutic mechanism may be related to its regulation of inflammation, immunity, and apoptosis.”
Key Findings:
- QJWJ is effective in the treatment of asthma, and the therapeutic mechanism may be related to its regulation of inflammation, immunity, and apoptosis.
- Published in Medicine (2025)
- Further research warranted to confirm findings
Alenbawi J et al. • Human genomics (2024)
“This meta-analysis examined the effects of Beta-Sitosterol.”
Key Findings:
- The meta-analysis replicated most of the reported variants, and our study provided significant support for the association of variants in SCARB1 and ABO with sitosterolemia.
- Evaluation of a polygenic risk score devised from European GWAS data showed moderate performance when applied to QBB (adjusted-R2 = 0.082).
- These findings provide new insights into the genetic architecture of phytosterol metabolism while showing the importance including under-represented populations in future GWAS studies.© 2024.
Qu P et al. • Medicine (2024)
“TCMD could be a satisfactory complementary and alternative therapy for GA.”
Key Findings:
- TCMD could be a satisfactory complementary and alternative therapy for GA.
- However, it should be verified by further studies.
- Future research could be conducted from the following active ingredients, targets, and signal pathways, such as wogonin, sitosterol, and sitosterol; AKT1, TNF, IL6, and TP53; and IL-17, HIF-1, and PI3K-AKT signaling pathway.
Koutsos A et al. • The American journal of clinical nutrition (2024)
“These findings support the efficacy of United Kingdom SFA dietary guidelines for the overall lowering of serum LDL cholesterol but showed marked variation in LDL cholesterol response.”
Key Findings:
- There was also an increase in plasma biomarkers of cholesterol intestinal absorption (β-sitosterol, campesterol, cholestanol), and synthesis (desmosterol) (P < 0.0001) and fold change in PBMC LDL-receptor mRNA expression relative to the higher-SFA/lower-UFA diet (P = 0.035).
- These findings support the efficacy of United Kingdom SFA dietary guidelines for the overall lowering of serum LDL cholesterol but showed marked variation in LDL cholesterol response.
- Further identification of the determinants of this variation will facilitate targeting and increasing the efficacy of these guidelines.
- The RISSCI-1 study was registered with ClinicalTrials.Gov (No.
Study Type Distribution
Goals This Supplement Supports
Related Goals
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.